Astellas

Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Bloomberg
Tue, 01/3/12 - 11:31 am
Aveo Pharmaceutical
Astellas
renal cell carcinoma
tivozanib
Zogenix, Astellas to end co-promotion for migraine injection
Reuters
Wed, 12/21/11 - 08:35 am
Astellas
Zogenix
migraines
Sumavel DosePro
FDA, EMA accept Astellas bladder drug for review
Pharma Times, UK
Fri, 11/11/11 - 01:04 pm
FDA
EMA
overactive bladder
Astellas
mirabegron
Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer
Seeking Alpha
Tue, 10/25/11 - 10:49 am
pancreatic cancer
Amgen
Celgene
Infinity
Oncolytics
Pharmacyclics
Immunomedics
Threshold Pharmaceuticals
Clovis Oncology
Novartis
Aduro BioTech
NewLink Genetics
Seattle Genetics
Bayer Schering
Astellas
Astellas halts development of anti-clotting drug
Reuters
Wed, 09/28/11 - 09:19 am
Astellas
YM150
anti-clotting
CHMP Recommends Astellas Pharma Europe Ltd.'s (APEL) DIFICLIR for Approval in the EU
Yahoo/PR NewsWire
Sat, 09/24/11 - 12:40 pm
Optimer Pharmaceuticals
Astellas
Dificlir
Clostridium Difficile
fidaxomicin
Astellas clot drug raises bleeding in heart study
Reuters
Tue, 08/30/11 - 09:44 am
Astellas
anticoagulants
Darexaban
Switching Partners Provides a Big Shot in the Arm
Motley Fool
Wed, 07/27/11 - 10:54 pm
Merck
Cardiome
Astellas
Pfizer
Bristol-Myers Squibb
JNJ
Merck snags Astellas' U.S. rights to IV vernakalant
Fierce Biotech
Wed, 07/27/11 - 02:39 pm
Vernakalant
Merck
Astellas
atrial fibrillation
Astellas eyes cancer drugs to stabilize profit picture
Fierce Pharma
Wed, 07/20/11 - 01:05 pm
Astellas
cancer
Vical jumps 7% on vaccine deal
Marketwatch
Fri, 07/15/11 - 02:38 pm
Vical
Astellas
vaccines
TransVax
CMV
Vical inks licensing deal with Astellas over vaccine for stem-cell transplant patients
Yahoo/AP
Fri, 07/15/11 - 01:07 am
Vical
licensing
Astellas
vaccines
stem cell transplant
Astellas to Sell Pfizer’s Caduet Drug in Japan From October
Bloomberg
Fri, 07/8/11 - 11:59 am
Astellas
Pfizer
Caduet
Japan
Astellas' patent sale gins $609M for new round of dealmaking
Fierce Biotech
Thu, 06/30/11 - 09:36 am
Astellas
patents
diabetes
OSI Pharmaceuticals
Seattle Genetics and Astellas start development of second experimental cancer drug
Yahoo/AP
Thu, 06/9/11 - 08:02 am
Seattle Genetics
Astellas
cancer
Medivation and Astellas Announce New Study Results Confirming Clinical Effects and Tolerability of MDV3100 in Advanced Prostate Cancer
Yahoo/MarketWire
Sat, 06/4/11 - 10:01 am
Medivation
Astellas
MDV3100
prostate cancer
5 Biotechs With Upcoming Clinical Trial Results
Motley Fool
Wed, 06/1/11 - 07:52 am
Amarin
AMR101
cabozantinib
Exelixis
HIV quad pill
Gilead Sciences
Medivation
MDV3100
Astellas
Vical
skin cancer
YM BioSciences
nimotuzumab
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Fierce Biotech
Thu, 05/19/11 - 02:08 pm
abiraterone
prostate cancer
Medivation
MDV3100
dimebon
Pfizer
Astellas
MDV3100 in New Phase II Study
Yahoo/Zacks
Sat, 05/14/11 - 12:52 pm
Medivation
MDV3100
prostate cancer
Casodex
AstraZeneca
Astellas
Comparing Medivation, Inc.'s and Johnson & Johnson's Prostate Cancer Drugs
Seeking Alpha
Mon, 03/21/11 - 02:56 pm
prostate cancer
Medivation
JNJ
Pfizer
Astellas
MDV3100
abiraterone

Pages